Home The role of MRI and CT for diagnosis and work-up in suspected ACS
Article Publicly Available

The role of MRI and CT for diagnosis and work-up in suspected ACS

  • Florian André EMAIL logo , Sebastian J. Buss and Matthias G. Friedrich
Published/Copyright: November 24, 2016

Abstract

This article describes the role of cardiovascular magnetic resonance (CMR) and cardiac computed tomography (CCT) in the diagnostic work-up of patients with suspected acute coronary syndrome (ACS). Recent studies on the principles, diagnostic targets, clinical utility, accuracy, prognostic relevance and implications for clinical decision-making are discussed and current state-of-the-art and novel approaches are presented. The authors recognize that in ACS, time is of the essence and therefore put a special emphasis on the feasibility of tomographic cardiac imaging in realistic clinical settings.

The need for diagnostic imaging in acute coronary syndrome

Chest pain suggesting acute coronary syndrome (ACS) is the second most frequent reasons for seeking acute medical care [1] and one of the most important cost factors in medicine. The diagnostic work-up and management of patients with chest pain account for more than 150 billion dollars in the USA alone [2]. ACS is the clinical entity resulting from severe acute myocardial ischemia, mostly due to a hemodynamically significant coronary artery stenosis or an intermittent or permanent occlusion of a coronary artery, typically triggered by plaque erosion or rupture. In myocardial infarction, it is often associated with the formation of a local thrombus, although the precise mechanisms are not well understood [3]. Insufficient myocardial perfusion, if not quickly resolved, leads to severe myocardial ischemia with subsequent cell death.

Other conditions such as acute myocarditis, stress-induced cardiomyopathy, hypertensive emergency and others can mimic ACS, yet are typically related to a mismatch of oxygen supply and demand based on an increased demand or on direct cell injury.

Once a primary coronary event is verified, the immediate establishment of coronary patency is essential. Cardiac troponin in combination with an electrocardiogram (ECG) is typically used in emergency settings for identifying patients in need for acute coronary revascularization. Echocardiography can reveal regional or global wall motion abnormalities and rule out pericardial effusion or assess for valvular dysfunction, but is not specific regarding the acuity of the disease, its etiology, or the severity of associated coronary lesions. Imaging, however, still plays an important role in patients with a low pre-test likelihood of ACS such as young age with absence of atherosclerotic risk factors. Furthermore, it is useful in patients with known complex triple-vessel disease or with inconsistent findings. Subjects presenting late after the onset of symptoms often benefit from a workup regarding preserved viability and the region of any inducible ischemia.

Among currently used imaging modalities, cardiovascular magnetic resonance (CMR) is unique in its ability to characterize tissue abnormalities with a high spatial resolution, specifically including acute and chronic ischemic injury of the myocardium. Short, yet comprehensive protocols can be integrated into the care of acute patients without adding significant time [4], [5], [6].

Cardiac computed tomography (CCT), on the other hand, provides accurate information on coronary anatomy in emergency settings and appears useful in patients with low to intermediate risk of coronary artery disease (CAD) or in specific cases with a need for ruling out pneumothorax, pulmonary embolism or aortic dissection [7], [8].

In this article, we review the evidence for using CCT and CMR in patients with ACS.

Diagnostic targets in ACS

The hallmarks of acute coronary events on a cellular level are a regional lack of blood supply, ischemia, intracellular and interstitial edema, oncosis/necrosis and contractile dysfunction. The main goal of the diagnostic workup in patients with suspected ACS is either excluding or confirming acute myocardial ischemia. Given the associated pathophysiologic abnormalities, this can be achieved by visualizing a regional perfusion deficit, myocardial edema or necrosis, ideally combined with an associated coronary occlusion or significant stenosis. The perfusion deficit is present right from the beginning and edema likely develops within less than 30 min [9].

While an increased level and accordingly significant kinetic of high-sensitivity troponin reliably identify myocardial injury, it is non-specific with respect to the etiology. Furthermore, patients with renal insufficiency often have high levels of troponin and, unfortunately, are also patients with an increased risk for contrast agent-induced renal failure. Acute myocarditis can present as acute myocardial infarction including increased troponin and ST elevation [10]. Thus, specific targets for a sufficiently fast imaging modality include coronary anatomy, perfusion as well as edema imaging and, in patients presenting late, imaging of myocardial necrosis (Table 1).

Table 1:

Specificity of diagnostic imaging targets for acute coronary syndrome.

TargetSpecificity for ACSSufficient with positive troponin?Specific for coronary territory
ECG: ST-elevation+++YesYes (limited for left circumflex artery)
High-sensitivity troponin increase/kinetics+++n.a.No
CCT: Coronary occlusion++Yes (if single occlusion)Yes
CCT: FFR++Uncertain (limited data)Yes
CMR: Perfusion deficit++Uncertain (limited data)Yes
CMR: Edema+++YesYes
CMR: Necrosis+NoYes

FFR, fractional flow reserve.

Furthermore, the extent of injury may have significant implications for prognosis and clinical management (e.g. intensive blood pressure treatment in patients with severe global ventricular dysfunction). Finally, imaging in patients with ACS should allow for detecting patients at risk for or with acute complications such as pericardial effusion, severe valvular dysfunction, aneurysms or imminent ventricular septal defects.

Principles and diagnostic targets of CMR in ACS

CMR allows for a quasi-simultaneous assessment of a multitude of diagnostic markers in the context of suspected ACS. The most important specific contribution is based on its tissue markers for acute ischemia.

Left-ventricular function: cine CMR

Cine CMR with its consistent image quality accurately identifies regional and global wall motion abnormalities. Typically, at least two cine slices can be acquired within a single breath-hold. While generally, contiguous stacks are recommended [11], [12], the acquisition of six long-axis views is faster and results are equally accurate [13]. Clearly defined regional wall motion abnormalities without associated wall thinning are consistent with recent ischemic injury, although cine imaging solely cannot exclude other etiologies. The same images allow for the assessment of regional or global systolic function, for a qualitative assessment of valvular function, pericardial effusion, and edema [14]. Figure 1 shows diastolic and systolic frames of a cine series in a patient with ACS. Overall, the left-ventricular function is a known prognostic marker in patients with ACS.

Figure 1: Cine CMR images at end-diastole (upper row) and end-systole (middle row) in a patient with acute ischemia in the territory of the left anterior descending (LAD) coronary artery.While there is only subtle dysfunction, the water-sensitive CMR images (lower low) show evidence of myocardial edema in the LAD territory (arrows).
Figure 1:

Cine CMR images at end-diastole (upper row) and end-systole (middle row) in a patient with acute ischemia in the territory of the left anterior descending (LAD) coronary artery.

While there is only subtle dysfunction, the water-sensitive CMR images (lower low) show evidence of myocardial edema in the LAD territory (arrows).

Edema imaging

Edema imaging by CMR has become the most efficient clinical tool to verify the presence, extent, and location of acute myocardial injury. It has been known for more than 30 years that an acute ischemic injury, despite a rather small net increase of absolute tissue water content, significantly increases myocardial T2 signal [15]. More recently, edema has been identified as a strong diagnostic marker [16], which is specific for acute vs. chronic ischemic injury [17]. Dark-blood water-sensitive (“T2-weighted”) images with fat saturation are typically applied [18]. Myocardial edema in a coronary territory showing an ischemic distribution pattern (subendocardial or transmural) is very specific for acute ischemic injury. Figure 2 shows a typical example of a reperfused acute myocardial infarction (Figure 2). The absence of an associated high signal intensity in late gadolinium enhancement (LGE) indicates fully reversible injury, which is, for example, found in stress-induced cardiomyopathy (“takotsubo”). Of note, edema-sensitive CMR is the only available in-vivo technique to assess the myocardium for edema, the most accurate in-vivo marker for acute myocardial injury.

Figure 2: CMR images in a patient with acute reperfused myocardial infarction after revascularization of the left circumflex (LCX) coronary artery.The cine images in diastole (left upper panel) and systole (right upper panel) show mild hypokinesis of the inferolateral wall. The LGE image (left lower panel) indicates largely transmural irreversible injury (arrow), which corresponds to transmural edema in the same region (right lower panel, arrow).
Figure 2:

CMR images in a patient with acute reperfused myocardial infarction after revascularization of the left circumflex (LCX) coronary artery.

The cine images in diastole (left upper panel) and systole (right upper panel) show mild hypokinesis of the inferolateral wall. The LGE image (left lower panel) indicates largely transmural irreversible injury (arrow), which corresponds to transmural edema in the same region (right lower panel, arrow).

However, its inherently low signal-to-noise ratio and susceptibility to motion artifacts can limit the quality of these images. More recently, T1 mapping [19], [20] and T2 mapping [21] have been introduced and may be more robust for detecting acute injury. While T1 mapping may show increased values in acute as well as in chronic stages of myocardial injury, T2 mapping detects mainly myocardial edema as result of an acute myocardial injury. Of note, recent controversial data indicated that T2 may show a transient (pseudo-) normalization about 24 h after the onset of ischemia [22].

Areas with low signal intensity in water-sensitive images may indicate myocardial hemorrhage which is a relatively frequent complication of acute coronary revascularization. The presence of a hypointense core also indicates an impaired prognosis [23].

Necrosis and scar imaging

Specific images acquired 10–30 min after the injection of gadolinium-based agents accurately visualize irreversible myocardial injury due to a delayed washout of the contrast agent from the extracellular compartment, a technique known as aforementioned late gadolinium enhancement (LGE) imaging. In the context of ACS, bright signal intensity in images, in which the signal intensity of tissue with normal washout kinetics is artificially set to very low values, indicates necrosis. LGE imaging is more sensitive than nuclear medicine techniques in detecting smaller infarcts and visualizes both, viable and non-viable tissue [24]. In acute myocardial infarction, areas of high signal intensity in LGE images may slightly overestimate the size of reperfused infarcts around 24 h after the event [25], likely due to reperfusion injury. It is important to keep in mind that if no water-sensitive CMR images are acquired, a clear discrimination from remote myocardial infarction is not possible. Figure 3 shows an example of an acute and a remote infarct in the same patient. Non-reperfused and late reperfused infarcts often show a very dark region within the infarcted area (Figure 4). This is a no-reflow zone that often reflects microvascular obstruction related to myocardial hemorrhage.

Figure 3: CMR in a patient with acute and chronic infarction. The cine images in diastole (left upper panel) and systole (right upper panel) show largely preserved systolic function.The LGE image (left lower panel) indicates largely transmural irreversible injury in the territory of the left circumflex artery (arrow), which corresponds to transmural edema in the same region (right lower panel, arrow). The LGE image, however, also shows a scar in the anterior segment (arrowhead), with the same region appearing unremarkable in the edema-sensitive images (right lower panel). The combination of increased signal intensity in LGE images (scar) and largely normal signal intensity in edema-sensitive images is consistent with remote myocardial infarction.
Figure 3:

CMR in a patient with acute and chronic infarction. The cine images in diastole (left upper panel) and systole (right upper panel) show largely preserved systolic function.

The LGE image (left lower panel) indicates largely transmural irreversible injury in the territory of the left circumflex artery (arrow), which corresponds to transmural edema in the same region (right lower panel, arrow). The LGE image, however, also shows a scar in the anterior segment (arrowhead), with the same region appearing unremarkable in the edema-sensitive images (right lower panel). The combination of increased signal intensity in LGE images (scar) and largely normal signal intensity in edema-sensitive images is consistent with remote myocardial infarction.

Figure 4: Late gadolinium enhancement image (4-chamber view) in a patient with acute, reperfused myocardial infarction of the LCX territory.A large inferolateral region (arrowheads) including the subendocardial layer is surrounded by high signal intensity (arrows), typical for the large no-reflow zone often found in patients with late reperfusion and myocardial hemorrhage.
Figure 4:

Late gadolinium enhancement image (4-chamber view) in a patient with acute, reperfused myocardial infarction of the LCX territory.

A large inferolateral region (arrowheads) including the subendocardial layer is surrounded by high signal intensity (arrows), typical for the large no-reflow zone often found in patients with late reperfusion and myocardial hemorrhage.

As an example for infarct-related complications, large transmural septal infarcts indicate a higher risk for an acute ventricular septal defect. Other complications detectable by CMR include pericarditis and pseudoaneurysms.

Principles of CCT in ACS

Cardiac CT

In the recent decades, CT has emerged as a valuable diagnostic modality in modern cardiovascular medicine as well as in emergency medicine. Especially in acute care, CT has two important features: 1) Its wide availability allows for the immediate examination of patients in most primary care hospital with emergency departments or chest pain units and not only in specialized tertiary centres. 2) The short scan durations enable the comprehensive assessment of critically ill patients.

Regarding ACS, two different acquisition protocols are of clinical interest. Coronary computed tomography angiography (CCTA) protocols for the assessment of the coronary arteries and triple rule out (TRO) protocols which also include the simultaneous examination of the thorax.

Coronary computed tomography angiography

The reliable evaluation of coronary arteries in clinical routine became possible over 10 years ago with the introduction of 64 multi-slice CT systems. Since then, the advances in scanner and post-processing technologies have led to a further improvement in diagnostic accuracy. State-of-the-art CT scanners attain spatial resolutions <0.25 mm and temporal resolutions <60 ms allowing for the examination of a broad variety of patients and clinical conditions.

While calcium scoring of the coronary calcified plaque burden is used for risk stratification, its utility in ACS is limited as about 5% of patients with occlusive but non-calcified CAD may be missed [26], [27]. In some cases, however, calcium scoring can serve as a gatekeeper for CCTA as a high burden of calcified plaques indicate the presence of a significant CAD and may impair the diagnostic quality of a subsequent CCTA significantly [28], [29].

CCTA features a high sensitivity and a negative predictive value up to 99% for significant CAD [30]. Thus, a normal CCTA excludes significant CAD with sufficient sensitivity and allows for a safe discharge of patients [31], [32]. Yet, the specificity of CCTA is limited due to its susceptibility to artifacts from calcified plaques or cardiac and respiratory motion. Especially high heart rates, arrhythmias, and poor patient conditions may lead to motion artifacts which impair the assessment of the coronary arteries. In consequence, CCTA is mostly applicable for patients presenting with chest pain with a low to intermediate risk for CAD whereas those with high probability should rather be assigned to other modalities. Furthermore, CCTA may be appropriate in patients with ambiguous findings or with symptoms resolving hours before presentation [8]. A recent meta-analysis showed that the use of CCTA for ACS in emergency departments can result in a cost reduction and length of stay compared to standard care whereas the number of invasive coronary angiographies and revascularizations increases [33]. While there are several studies focusing on the outcome of patients with stable angina assessed with CCTA, outcome data for patients presenting with ACS are still scarce.

Triple rule out

Aside from CAD, acute chest pain can be caused by other, potential life-threatening pathologies. TRO protocols are designed to provide sufficient contrast of the coronary arteries, pulmonary arteries as well as the thoracic aorta, in order to allow for the assessment of CAD, pulmonary embolism (PE), aortic dissection (AD) as well as pneumothorax and traumatic injuries by a single acquisition. Although the image quality of TRO protocols is similar to CCTA protocols, the exposure to radiation and the amount of contrast medium are higher [34]. Therefore, dedicated CT examinations are recommended if the differential diagnosis can be narrowed [8]. If the leading diagnosis is PE or AD, CT is recommended because of its high diagnostic accuracy [8], [35], [36]. However, if such a risk is low, the diagnostic benefit of a TRO protocol over a CCTA is small and its use rarely appears appropriate [8], [34]. Nevertheless, in patients with unclear leading diagnosis, who have a relevant risk for AD, CAD or PE, the use of TRO protocols may be of diagnostic value and therefore warranted. Figure 5 shows the diagnostic benefit of a TRO protocol in a patient with equivocal symptoms and biomarkers.

Figure 5: Triple rule out study of a patient who presented with unclear leading diagnosis and inconclusive biomarkers at the chest pain unit.The CCT revealed a massive pulmonary embolism (arrows) as well as a severe stenosis of the proximal LAD (asterisk).
Figure 5:

Triple rule out study of a patient who presented with unclear leading diagnosis and inconclusive biomarkers at the chest pain unit.

The CCT revealed a massive pulmonary embolism (arrows) as well as a severe stenosis of the proximal LAD (asterisk).

The so-called quadruple rule out protocols extent the longitudinal scan coverage of TRO protocols to the skull base to allow for the assessment of the neck and intracranial arteries. Although rarely used, these protocols may be of avail in patients with syncope or suspected ischemic cerebrovascular events.

CCT image acquisition

CCT scans should be performed on CT systems with at least 64 slices, if available, to allow for a reliable detection of coronary artery stenosis. Prior to the scan, nitrates are administered to improve the accessibility of the coronary tree. Furthermore, β-blockers may be given to reduce the heart rate and thereby improve image quality and allow for the application of advanced dose reduction acquisition protocols.

CCT requires synchronization with cardiac motion and is attained by ECG-gating. In retrospective protocols, the image acquisition comprises the whole cardiac cycle resulting in a lower susceptibility to artifacts due to arrhythmias. In addition, they allow for dynamic measurements, e.g. for the assessment of stroke volumes and ejection fractions. Yet, these protocols are associated with a considerable radiation exposure for the patient. In prospective protocols the acquisition is performed at a prespecified point of the cardiac cycle, mostly in the end-diastolic or end-systolic phase, leading to significant radiation dose reductions. In addition, state-of-the-art CT scanners offer special acquisition modes as high volume axial modes or high-pitch spiral dual source protocols. In combination with advanced reconstruction algorithms radiation doses below 1.0 mSv for CCTA can be reached [37], [38].

As the distribution of the contrast medium after the injection depends on individual factors such as cardiac output, which may vary significantly between patients, bolus timing or triggering techniques are usually applied. For bolus timing, a small test bolus is injected and dynamic measurements of the X-ray attenuation are performed in one or several regions of interests (ROI) to estimate the time/time to peak of the contrast medium arrival. This time is used to optimize the delay between contrast medium injection and start of the image acquisition of the subsequent actual scan. For bolus triggering, the entire volume of the contrast medium is injected and the scan is triggered once a threshold value is reached in a specified ROI.

Specific cardiac reconstruction algorithms are applied to generate images from the acquired raw data. Various signal processing algorithms (kernels) are employed to optimize the visualization of different anatomical structures. In general, “soft” kernels are most suitable for soft tissues and the coronary vessels whereas “sharp” or “hard” kernels are better suitable for calcified plaques or coronary stent assessment. Advanced iterative reconstruction algorithms, which have been introduced in CCT in the recent years, reduce image noise and artifacts resulting in an improved image quality. Consequently, they may allow for significant dose reductions for CCTA in clinical routine [39].

Advanced technologies

While CCTA allows for the detailed assessment of the morphology of coronary artery stenosis, it does not provide information about their hemodynamic significance. This issue is addressed by two recently introduced techniques: virtual fractional flow reserve derived from CCTA (vFFRCT) and stress CT perfusion.

The fractional flow reserve (FFR), which is measured with a pressure wire at invasive coronary angiography, is the current reference standard to evaluate the rheological severity of a coronary artery stenosis. In vFFRCT computational fluid dynamics are applied to anatomical models based on the prior acquired CCTA study to estimate the FFR. First studies demonstrated a higher diagnostic accuracy for the identification of hemodynamic relevant stenosis compared to CCTA [40], [41]. Yet, vFFRCT requires a CCTA studies with a sufficient image quality which is a crucial point in ACS patients. To date, several issues have to be solved before this technique can be implemented in clinical routine, as 20% of scans are rejected because of insufficient image quality and a the computing algorithm is still not disclosed [42]. Thus, vFFRCT is presently not feasible in patients with ACS.

In stress CT perfusion protocols, vasodilators such as adenosine or regadenoson are applied in addition to contrast medium to assess for myocardial perfusion deficits. In static CT perfusion imaging, a single acquisition is performed during first-pass contrast enhancement whereas in dynamic CT perfusion imaging several consecutive image acquisitions are conducted. The latter allows for a more reliable acquisition of the peak attenuation and the quantification of hemodynamic parameters as the myocardial blood flow. However, dynamic CT perfusion imaging is associated with a significantly higher radiation exposure than static CT perfusion imaging. Stress CT perfusion has shown to improve the diagnostic accuracy of CCTA for the identification of physiological relevant coronary stenosis in several trials [43], [44]. Yet some issues still have to be solved before they can be implemented in clinical routine [45].

Clinical application of comprehensive CCT and CMR

In patients presenting with suspected ACS, a rapid diagnostic workup is crucial. Physical exam, ECG and troponin values typically provide enough information for therapeutic decision-making. But if additional information is necessary to confirm or rule out a specific diagnosis, CCT and CMR can be very useful. On top of the ECG and troponin, imaging is useful 1) to differentiate between ischemic and non-ischemic injury, 2) to identify the culprit lesion and 3) differentiation from other causes. Of note, poor patient conditions may result in an impaired image quality reducing the diagnostic value of the respective imaging modality significantly. Especially in acute patients, a closer consideration between the possibly gained diagnostic information by CCT or CMR and the required effort, time and resources is necessary.

A single CMR scan allows for an accurate quantitative assessment of ventricular function plus imaging of edema and necrosis, which specifically can identify acute ischemic injury, the territory of the culprit artery and also provides prognostic information. While CMR typically provides markers for a diagnosis in patients with the clinical appearance of ACS, however, the integration into the clinical context may be difficult. Immediate access to magnetic resonance imaging (MRI) scanners is not available on many sites. Further, in most centers, the MRI equipment is administered by radiology departments and thus scans of unstable patients require additional effort to ensure safety. While the image acquisitions themselves are safe and the patient is well supervised, the presence of an adequately trained physician is more important than in other typical MRI indications. Therefore, the lack of physicians with sufficient expertise and experience in reading CMR scans is an additional limiting factor. Finally, clinical workflows in most institutions do not include rapid access to MRI scanners. While CMR can visualize the anatomy of the proximal coronary arteries and thus rule out coronary anomalies in younger patients, more distal lesions cannot be assessed yet at a robust and diagnostic level.

In patients with suspected ACS, CCT is very useful to rule out or rule in coronary artery stenosis and can be integrated into such clinical settings. CT systems are available in most institutions as part of the diagnostic workup of patients presenting to the emergency department or chest pain unit. As a CT coronary angiogram does not require extensive preparation, it appears easier to integrate CCT into the care of ACS patients. The scan itself is fast (typically <10 min) and thus less time-consuming than current CMR protocols, which may be critical in a setting where every minute counts. CCT however, at present, does not provide specific information on the extent of any injury and, in case of severe multi-vessel disease, cannot specifically differentiate the culprit from a bystander lesion. In patients with unclear leading diagnosis, TRO offers the possibility to assess several potential life-threatening pathologies by one single examination.

Besides a thorough diagnostic workup of both modalities offer the possibility of a reduction of the length of stay and patient care costs [33], [46], [47]. Aside from medical considerations, the on-site availability of adequate scanners as well as the expertise of the medical staff on hand play an important role in the selection of the appropriate imaging modality.

Clinical scenarios of ACS with a need for tomographic imaging

The following scenarios may be present:

  1. Patients with typical clinical appearance yet absence of acute or metabolic risk markers

    In patients presenting with symptoms suggesting ACS yet with a normal ECG and normal troponin values, the likelihood of ACS is small, yet in the presence of very typical clinical symptoms and risk factors, physicians may be reluctant to discharge patients and thus, there is a role for imaging to rule out recent or inducible ischemia. CCT can be used to rule out coronary artery stenosis, while CMR would be performed to rule out any recent ischemic event (edema-sensitive CMR), previous myocardial infarction (with false negative ECG) or inducible ischemia. CCT should not be performed in young women because of the associated small yet significant risk for breast cancer.

  2. Patients with positive troponin yet normal ECG, low metabolic risk and atypical symptoms

    This would include patients who have an increased troponin yet nothing else indicating ACS. In many cases, especially in younger men, this may reflect acute (viral) myocarditis. Myocardial injury is probably present yet more likely non-ischemic. A CMR scan would allow for confirming acute injury as well as its localization, while also quantifying its extent. Especially in younger patients, the absence of any radiation is an advantage of CMR. The risk of a coronary anomaly, however, has to be kept in mind and therefore, the CMR protocol has to include imaging of the proximal course of the coronary artery.

  3. Patients with ACS yet non-obstructed coronary arteries

    Imaging may also play a significant role after an invasive coronary angiography. In about 6% of patients the coronary artery status does not explain clinical presentation and positive markers, an entity now known as myocardial infarction with non-obstructed coronary arteries (MINOCA) [48]. CMR is the most suitable technique to identify the underlying etiology. The regional distribution and characteristics of the myocardial lesion will typically provide sufficient information to differentiate an atherosclerotic coronary event from embolism, inflammation or infiltrative myocardial disease.

Patients with ST-elevation myocardial infarction (STEMI) should be referred directly to invasive coronary angiography. Echocardiography, which may serve for the assessment of the global and regional ventricular function, valvular dysfunctions and dissection membranes, is not included in this scheme.

The guidelines of various different societies, included in Table 2, may deviate in some cases [8], [35], [36], [49], [50]. Thus, the authors attempted to provide uniform clinically applicable recommendations. Yet, in daily practice, the physician may refer to the respective guideline.

Table 2:

Recommendation for imaging modality in institutions with rapid access to CCT and CMR.

Troponin and ECGPreferred modality
Risk for CAD
(A) Typical chest pain (angina pectoris) indicative for ACS
AnyPositiveCoronary

Angiography
Low-intermediateInitially negativeCCT
Low-intermediateSequentially negative/inconclusiveCCT/CMR
HighSequentially negativeCoronary angiography/CMR
Known CADSequentially negativeCMR/coronary angiography
CAD very unlikely, signs of inflammationPositiveCMR if suspected myocardial diseases, e.g. myocarditis and other infiltrative or non-infiltrative cardiomyopathies
CAD ruled-outPositiveCMR
Leading diagnosis

(B) Atypical chest pain or dyspnea
Pulmonary embolismMay be positiveCT
Aortic dissectionMay be positiveCCT (ECG-triggering is of advantage)
Myocarditis and other infiltrative or non-infiltrative cardiomyopathiesMay be positiveCMR
Unclear leading diagnosis and relevant risk for CAD, PA, ADMay be positiveCCT (TRO protocol)

Summary

In patients with suspected ACS, CMR and CCT are powerful diagnostic tools and can provide important additional information beyond clinical markers, ECG, and troponin. Thus, even considering the critical factor of time, CCT and CMR can be applied, especially in patients with equivocal findings or low overall risk. While CCT can exclude the presence of significant coronary artery stenosis with high sensitivity and a high negative predictive value and thus can be very useful in patients with low or intermediate risk, CMR allows for a more specific assessment of the etiology of myocardial injury. Access to these modalities in emergency room environments is still a limitation in many institutions.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. National Hospital Ambulatory Medical Care Survey: 2011 Emergency Department Summary Tables. Atlanta, GA: Centers for Disease Control and Prevention, 2011.Search in Google Scholar

2. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Executive summary: heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation 2010;121:948–54.10.1161/CIRCULATIONAHA.109.192666Search in Google Scholar

3. Toutouzas K, Benetos G, Karanasos A, Chatzizisis YS, Giannopoulos AA, Tousoulis D. Vulnerable plaque imaging: updates on new pathobiological mechanisms. Eur Heart J 2015;36:3147–54.10.1093/eurheartj/ehv508Search in Google Scholar

4. Kwong RY, Schussheim AE, Rekhraj S, Aletras AH, Geller N, Davis J, et al. Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation 2003;107:531–7.10.1161/01.CIR.0000047527.11221.29Search in Google Scholar

5. Steen H, Madadi-Schroeder M, Lehrke S, Lossnitzer D, Giannitsis E, Katus HA. Staged cardiovascular magnetic resonance for differential diagnosis of troponin T positive patients with low likelihood for acute coronary syndrome. J Cardiovasc Magn Reson 2010;12:51.10.1186/1532-429X-12-51Search in Google Scholar

6. Raman SV, Simonetti OP, Winner MW, 3rd, Dickerson JA, He X, Mazzaferri EL, Jr., et al. Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol 2010;55:2480–8.10.1016/j.jacc.2010.01.047Search in Google Scholar

7. Hoffmann U, Bamberg F, Chae CU, Nichols JH, Rogers IS, Seneviratne SK, et al. Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (rule out myocardial infarction using computer assisted tomography) trial. J Am Coll Cardiol 2009;53:1642–50.10.1016/j.jacc.2009.01.052Search in Google Scholar

8. Rybicki FJ, Udelson JE, Peacock WF, Goldhaber SZ, Isselbacher EM, Kazerooni E, et al. 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force. J Am Coll Cardiol 2016;67:853–79.10.1016/j.jacc.2015.09.011Search in Google Scholar

9. Abdel-Aty H, Cocker M, Meek C, Tyberg JV, Friedrich MG. Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. J Am Coll Cardiol 2009;53:1194–201.10.1016/j.jacc.2008.10.065Search in Google Scholar

10. Sarda L, Colin P, Boccara F, Daou D, Lebtahi R, Faraggi M, et al. Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol 2001;37:786–92.10.1016/S0735-1097(00)01201-8Search in Google Scholar

11. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E, Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized P. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson 2013;15:91.10.1186/1532-429X-15-91Search in Google Scholar PubMed PubMed Central

12. Friedrich MG, Larose E, Patton D, Dick A, Merchant N, Paterson I, et al. Canadian Society for Cardiovascular Magnetic Resonance (CanSCMR) recommendations for cardiovascular magnetic resonance image analysis and reporting. Can J Cardiol 2013;29:260–5.10.1016/j.cjca.2012.07.007Search in Google Scholar

13. Childs H, Ma L, Ma M, Clarke J, Cocker M, Green J, et al. Comparison of long and short axis quantification of left ventricular volume parameters by cardiovascular magnetic resonance, with ex-vivo validation. J Cardiovasc Magn Reson 2011;13:40.10.1186/1532-429X-13-40Search in Google Scholar

14. Kumar A, Beohar N, Arumana JM, Larose E, Li D, Friedrich MG, et al. CMR imaging of edema in myocardial infarction using cine balanced steady-state free precession. JACC Cardiovasc Imaging 2011;4:1265–73.10.1016/j.jcmg.2011.04.024Search in Google Scholar

15. Higgins CB, Herfkens R, Lipton MJ, Sievers R, Sheldon P, Kaufman L, et al. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol 1983;52:184–8.10.1016/0002-9149(83)90093-0Search in Google Scholar

16. Friedrich MG. Myocardial edema – a new clinical entity? Nat Rev Cardiol 2010;7:292–6.10.1038/nrcardio.2010.28Search in Google Scholar PubMed

17. Abdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, Kumar A, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004;109:2411–6.10.1161/01.CIR.0000127428.10985.C6Search in Google Scholar PubMed

18. Simonetti OP, Finn JP, White RD, Laub G, Henry DA. “Black blood” T2-weighted inversion-recovery MR imaging of the heart. Radiology 1996;199:49–57.10.1148/radiology.199.1.8633172Search in Google Scholar PubMed

19. Dall’Armellina E, Piechnik SK, Ferreira VM, Si QL, Robson MD, Francis JM, et al. Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson 2012;14:15.10.1186/1532-429X-14-15Search in Google Scholar PubMed PubMed Central

20. Messroghli DR, Niendorf T, Schulz-Menger J, Dietz R, Friedrich MG. T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson 2003;5:353–9.10.1081/JCMR-120019418Search in Google Scholar

21. Verhaert D, Thavendiranathan P, Giri S, Mihai G, Rajagopalan S, Simonetti OP, et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging 2011;4:269–78.10.1016/j.jcmg.2010.09.023Search in Google Scholar PubMed PubMed Central

22. Fernandez-Jimenez R, Garcia-Prieto J, Sanchez-Gonzalez J, Aguero J, Lopez-Martin GJ, Galan-Arriola C, et al. Pathophysiology underlying the bimodal edema phenomenon after myocardial ischemia/reperfusion. J Am Coll Cardiol 2015;66:816–28.10.1016/j.jacc.2015.06.023Search in Google Scholar

23. Eitel I, Kubusch K, Strohm O, Desch S, Mikami Y, de Waha S, et al. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction. Circ Cardiovasc Imaging 2011;4:354–62.10.1161/CIRCIMAGING.110.960500Search in Google Scholar

24. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374–9.10.1016/S0140-6736(03)12389-6Search in Google Scholar

25. Jablonowski R, Engblom H, Kanski M, Nordlund D, Koul S, van der Pals J, et al. Contrast-enhanced CMR overestimates early myocardial infarct size: mechanistic insights using ECV measurements on day 1 and day 7. JACC Cardiovasc Imaging 2015;8:1379–89.10.1016/j.jcmg.2015.08.015Search in Google Scholar PubMed

26. Kelly JL, Thickman D, Abramson SD, Chen PR, Smazal SF, Fleishman MJ, et al. Coronary CT angiography findings in patients without coronary calcification. AJR Am J Roentgenol. 2008;191:50–5.10.2214/AJR.07.2954Search in Google Scholar PubMed

27. Marwan M, Ropers D, Pflederer T, Daniel WG, Achenbach S. Clinical characteristics of patients with obstructive coronary lesions in the absence of coronary calcification: an evaluation by coronary CT angiography. Heart 2009;95:1056–60.10.1136/hrt.2008.153353Search in Google Scholar PubMed

28. Meijs MF, Meijboom WB, Prokop M, Mollet NR, van Mieghem CA, Doevendans PA, et al. Is there a role for CT coronary angiography in patients with symptomatic angina? Effect of coronary calcium score on identification of stenosis. Int J Cardiovasc Imaging 2009;25:847–54.10.1007/s10554-009-9485-7Search in Google Scholar PubMed PubMed Central

29. van Werkhoven JM, de Boer SM, Schuijf JD, Cademartiri F, Maffei E, Jukema JW, et al. Impact of clinical presentation and pretest likelihood on the relation between calcium score and computed tomographic coronary angiography. Am J Cardiol 2010;106:1675–9.10.1016/j.amjcard.2010.08.014Search in Google Scholar PubMed

30. Paech DC, Weston AR. A systematic review of the clinical effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of suspected coronary artery disease. BMC Cardiovasc Disord 2011;11:32.10.1186/1471-2261-11-32Search in Google Scholar PubMed PubMed Central

31. Samad Z, Hakeem A, Mahmood SS, Pieper K, Patel MR, Simel DL, et al. A meta-analysis and systematic review of computed tomography angiography as a diagnostic triage tool for patients with chest pain presenting to the emergency department. J Nucl Cardiol 2012;19:364–76.10.1007/s12350-012-9520-2Search in Google Scholar PubMed

32. Schlett CL, Banerji D, Siegel E, Bamberg F, Lehman SJ, Ferencik M, et al. Prognostic value of CT angiography for major adverse cardiac events in patients with acute chest pain from the emergency department: 2-year outcomes of the ROMICAT trial. JACC Cardiovasc Imaging 2011;4:481–91.10.1016/j.jcmg.2010.12.008Search in Google Scholar PubMed PubMed Central

33. Hulten E, Pickett C, Bittencourt MS, Villines TC, Petrillo S, Di Carli MF, et al. Outcomes after coronary computed tomography angiography in the emergency department: a systematic review and meta-analysis of randomized, controlled trials. J Am Coll Cardiol 2013;61:880–92.10.1016/j.jacc.2012.11.061Search in Google Scholar PubMed

34. Burris AC, 2nd, Boura JA, Raff GL, Chinnaiyan KM. Triple Rule Out Versus Coronary CT Angiography in Patients With Acute Chest Pain: Results From the ACIC Consortium. JACC Cardiovasc Imaging 2015;8:817–25.10.1016/j.jcmg.2015.02.023Search in Google Scholar PubMed

35. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2873–926.10.1093/eurheartj/ehu281Search in Google Scholar PubMed

36. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014;35:3033–69, 69a–k.10.1093/eurheartj/ehu283Search in Google Scholar PubMed

37. Hell MM, Bittner D, Schuhbaeck A, Muschiol G, Brand M, Lell M, et al. Prospectively ECG-triggered high-pitch coronary angiography with third-generation dual-source CT at 70 kVp tube voltage: feasibility, image quality, radiation dose, and effect of iterative reconstruction. J Cardiovasc Comput Tomogr 2014;8:418–25.10.1016/j.jcct.2014.09.003Search in Google Scholar PubMed

38. Park CH, Lee J, Oh C, Han KH, Kim TH. The feasibility of sub-millisievert coronary CT angiography with low tube voltage, prospective ECG gating, and a knowledge-based iterative model reconstruction algorithm. Int J Cardiovasc Imaging. 2015;31(Suppl 2):197–203.10.1007/s10554-015-0795-7Search in Google Scholar PubMed

39. Deseive S, Chen MY, Korosoglou G, Leipsic J, Martuscelli E, Carrascosa P, et al. Prospective Randomized Trial on Radiation Dose Estimates of CT Angiography Applying Iterative Image Reconstruction: The PROTECTION V Study. JACC Cardiovasc Imaging 2015;8:888–96.10.1093/eurheartj/eht310.P4680Search in Google Scholar

40. Koo BK, Erglis A, Doh JH, Daniels DV, Jegere S, Kim HS, et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. J Am Coll Cardiol 2011;58:1989–97.10.1016/j.jacc.2011.06.066Search in Google Scholar PubMed

41. Norgaard BL, Leipsic J, Gaur S, Seneviratne S, Ko BS, Ito H, et al. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). J Am Coll Cardiol 2014;63:1145–55.10.1016/j.jacc.2013.11.043Search in Google Scholar PubMed

42. Morris PD, van de Vosse FN, Lawford PV, Hose DR, Gunn JP. “Virtual” (Computed) fractional flow reserve: current challenges and limitations. JACC Cardiovasc Interv 2015;8:1009–17.10.1016/j.jcin.2015.04.006Search in Google Scholar PubMed PubMed Central

43. Cury RC, Kitt TM, Feaheny K, Blankstein R, Ghoshhajra BB, Budoff MJ, et al. A randomized, multicenter, multivendor study of myocardial perfusion imaging with regadenoson CT perfusion vs single photon emission CT. J Cardiovasc Comput Tomogr 2015;9:103–12 e1–2.10.1016/j.jcct.2015.01.002Search in Google Scholar PubMed

44. Rochitte CE, George RT, Chen MY, Arbab-Zadeh A, Dewey M, Miller JM, et al. Computed tomography angiography and perfusion to assess coronary artery stenosis causing perfusion defects by single photon emission computed tomography: the CORE320 study. Eur Heart J 2014;35:1120–30.10.1093/eurheartj/eht488Search in Google Scholar PubMed PubMed Central

45. Rossi A, Merkus D, Klotz E, Mollet N, de Feyter PJ, Krestin GP. Stress myocardial perfusion: imaging with multidetector CT. Radiology 2014;270:25–46.10.1148/radiol.13112739Search in Google Scholar PubMed

46. Miller CD, Case LD, Little WC, Mahler SA, Burke GL, Harper EN, et al. Stress CMR reduces revascularization, hospital readmission, and recurrent cardiac testing in intermediate-risk patients with acute chest pain. JACC Cardiovasc Imaging 2013;6:785–94.10.1016/j.jcmg.2012.11.022Search in Google Scholar PubMed PubMed Central

47. Miller CD, Hwang W, Case D, Hoekstra JW, Lefebvre C, Blumstein H, et al. Stress CMR imaging observation unit in the emergency department reduces 1-year medical care costs in patients with acute chest pain: a randomized study for comparison with inpatient care. JACC Cardiovasc Imaging 2011;4:862–70.10.1016/j.jcmg.2011.04.016Search in Google Scholar PubMed PubMed Central

48. Pasupathy S, Air T, Dreyer RP, Tavella R, Beltrame JF. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation 2015;131:861–70.10.1161/CIRCULATIONAHA.114.011201Search in Google Scholar PubMed

49. Task Force M, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949–3003.10.1093/eurheartj/eht296Search in Google Scholar PubMed

50. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267–315.10.1093/eurheartj/ehv320Search in Google Scholar PubMed

Received: 2016-7-22
Accepted: 2016-11-2
Published Online: 2016-11-24
Published in Print: 2016-12-1

©2016 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 26.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/dx-2016-0029/html
Scroll to top button